Enanta Pharmaceuticals Reports Financial Results for its Fiscal Third Quarter Ended June 30, 2019

Go back to Enanta Pharmaceuticals Reports Financial Results for its Fiscal Third Quarter Ended June 30, 2019
ENANTA PHARM (NASDAQ: ENTA) Delayed: 14.50 -0.01 (0.07%)
Previous Close $14.51    52 Week High $34.49 
Open $14.66    52 Week Low $20.39 
Day High $14.86    P/E N/A 
Day Low $14.26    EPS $-3.18 
Volume 25,261